Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A bioinformatic approach to characterize the vitellogenin receptor and the low density lipoprotein receptor superfamily in the newt Cynops orientalis. | Sci Rep | 2025 | 39870874 | PubTator, text mining | PubMed |
| Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. | Lancet Neurol | 2025 | 39862880 | PubTator, text mining | PubMed |
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. | Lancet Neurol | 2025 | 39862879 | PubTator, text mining | PubMed |
| The impact of LRP4 mutations on HCC recurrence and immunotherapy response. | Hepatology | 2025 | 39817746 | PubTator, text mining | PubMed |
| Biallelic variants in AGRN in a family with recurrent pregnancy losses and fetal akinesia deformation sequence. | Clin Dysmorphol | 2025 | 39807604 | PubTator, text mining | PubMed |
| Response to Pyridostigmine in Congenital Myasthenia with LRP4 Mutation. | Indian J Pediatr | 2025 | 39739258 | PubTator, text mining | PubMed |
| LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma. | Hepatology | 2025 | 39723987 | PubTator, text mining | PubMed |
| Regeneration mechanisms and therapeutic strategies for neuromuscular junctions in aging and diseases. | Neural Regen Res | 2025 | 39657086 | PubTator, text mining | PubMed |
| Heavy duty. | Surv Ophthalmol | 2025 | 39521071 | PubTator, text mining | PubMed |
| Mapping the sclerostin-LRP4 binding interface identifies critical interaction hotspots in loops 1 and 3 of sclerostin. | FEBS Lett | 2025 | 39443289 | PubTator, text mining | PubMed |
| Identification of potential biomarkers of papillary thyroid carcinoma. | Endocrine | 2025 | 39400774 | PubTator, text mining | PubMed |
| Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review. | Neuroepidemiology | 2025 | 39380477 | PubTator, text mining | PubMed |
| Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study. | Intern Med | 2025 | 38897960 | PubTator, text mining | PubMed |
| A clinical perspective on muscle specific kinase antibody positive myasthenia gravis. | Front Immunol | 2024 | 39703505 | PubTator, text mining | PubMed |
| Surgical treatment of thymic epithelial tumor and myasthenia gravis. | Front Surg | 2024 | 39624461 | PubTator, text mining | PubMed |
| Systemic Lipid Metabolism Dysregulation as a Possible Driving Force of Fracture Non-Unions? | Bioengineering (Basel) | 2024 | 39593795 | PubTator, text mining | PubMed |
| Regulation of miR-206 in denervated and dystrophic muscles, and its effect on acetylcholine receptor clustering. | J Cell Sci | 2024 | 39575567 | PubTator, text mining | PubMed |
| Lipoprotein Receptor-Related Protein 4 Antibody Positivity in the Youngest Patient in the Caucasus Region: A Case Report. | Cureus | 2024 | 39385918 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing. | J Tissue Eng | 2024 | 39371940 | PubTator, text mining | PubMed |
| The changing landscape of autoantibody testing in myasthenia gravis in the setting of novel drug treatments. | Clin Biochem | 2024 | 39357636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=6